Avadel Pharmaceuticals PLC (AVDL) — Capital Reinvestment Ratio
Latest as of September 2025:
0.00x
Avadel Pharmaceuticals PLC (AVDL) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($23.26 Million) in capital expenditures ($10.76K). See cash generation quality of Avadel Pharmaceuticals PLC to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$23.26 Million
USD
Capital Expenditures
$10.76K
USD
Data as of
Sep 2025
Most recent filing
Avadel Pharmaceuticals PLC Capital Reinvestment Ratio (2002–2017)
This chart tracks Avadel Pharmaceuticals PLC's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Avadel Pharmaceuticals PLC (2002–2017)
Year-by-year Capital Reinvestment Ratio for Avadel Pharmaceuticals PLC from 2002 to 2017. For live market cap and broader valuation context, see market value of Avadel Pharmaceuticals PLC.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 3.22x | $16.66 Million | $53.70 Million | ▲ +4972.3% |
| 2016 | 0.06x | $18.90 Million | $1.20 Million | ▲ +228.8% |
| 2015 | 0.02x | $84.29 Million | $1.63 Million | ▼ -91.1% |
| 2009 | 0.22x | $8.20 Million | $1.77 Million | ▼ -7.0% |
| 2003 | 0.23x | $12.23 Million | $2.84 Million | ▲ +42.0% |
| 2002 | 0.16x | $8.77 Million | $1.44 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow